OTC · Financial Statements

Innovation1 Biotech Inc. (IVBT) Financial Statements

$0.00 OTC: IVBT Market Cap $4494

Innovation1 Biotech Inc. most recently reported annual revenue of $0, net profit of $-6.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20192020202120222023
Revenue$0$0$0$0$0
Operating Profit$-1.0M$0$0$-5.0M$-1.0M
Net Profit$0$-3.0M$1.0M$-41.0M$-6.0M
EPS$-0.39$-8.59$5.53$-2.73$-0.70
Op Margin-791.2%-18374.3%-8390.9%——

Balance Sheet (USD)

Metric20192020202120222023
Total Assets$0$0$0$44.0M$0
Total Liabilities$0$3.0M$0$41.0M$4.0M
Cash$0$0$0$0$0
Borrowings$0$1.0M$0$1.0M$0

Cash Flow (USD)

Metric20192020202120222023
Operating Cash Flow$-1.0M$0$0$-3.0M$-1.0M
Investing Cash Flow$0$0$0$-1.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$-1.0M$0$0$0$0
Free Cash Flow$-1.0M$0$0$-3.0M$-1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.03
FCF Yield-13800.62%
Quick Ratio0.02
Interest Coverage-5.43
Return 1Y0.00%
Return 3Y-99.88%
Return 5Y—

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
IVBT Overview IVBT Dividend Run Stock Screener